Randomized Comparison of ABVD and MOPP/ABV Hybrid for the Treatment of Advanced Hodgkin’s Disease: Report of an Intergroup Trial

Categorical Data Analysis

1991 • 9,374 citations

A Multiple Testing Procedure for Clinical Trials

1979 • 3,139 citations

Discrete sequential boundaries for clinical trials

1983 • 1,710 citations

A Prognostic Score for Advanced Hodgkin's Disease

1998 • 1,694 citations

Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVD

1992 • 1,159 citations

Breast Cancer and Other Second Neoplasms after Childhood Hodgkin's Disease

1996 • 904 citations

Analysing Survival Data From Clinical Trials and Observational Studies

1996 • 638 citations

Leukemia Following Hodgkin's Disease

1990 • 502 citations

Curability of Advanced Hodgkin's Disease with Chemotherapy

1980 • 466 citations

Hematologic Neoplasia in Patients Treated for Hodgkin's Disease

1977 • 452 citations

Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy.

1987 • 384 citations

Second acute leukemia and other malignancies following treatment for Hodgkin's disease.

1986 • 318 citations

Stanford V and Radiotherapy for Locally Extensive and Advanced Hodgkin's Disease: Mature Results of a Prospective Clinical Trial

2002 • 309 citations

Incidence of Acute Nonlymphocytic Leukemia, Preleukemia, and Acute Myeloproliferative Syndrome up to 10 Years after Treatment of Hodgkin's Disease

1982 • 288 citations

Design and analysis of group sequential tests based on the type I error spending rate function

1987 • 287 citations

Decreasing Risk of Leukemia with Prolonged Follow-up after Chemotherapy and Radiotherapy for Hodgkin's Disease

1987 • 226 citations

MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease.

1985 • 178 citations

Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.

1997 • 160 citations

Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease

1982 • 143 citations

Assessment of the Stanford V Regimen and Consolidative Radiotherapy for Bulky and Advanced Hodgkin’s Disease: Eastern Cooperative Oncology Group Pilot Study E1492

2000 • 122 citations

Stanford V and Radiotherapy for Locally Extensive and Advanced Hodgkin’s Disease: Mature Results of a Prospective Clinical Trial

2002 • 110 citations

MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial.

1998 • 108 citations

Extending SAS® Survival Analysis Techniques for Medical Research

1998 • 76 citations

Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease

1982 • 14 citations

Policies for interim analysis and interim reporting of results.

1985 • 6 citations